SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News

BMI Extremes Tied to Worse Pregnancy Outcomes With ART

BMI appears to have a greater impact on pregnancy continuation than on achieving initial implantation or pregnancy. Study findings suggest promoting proactive BMI optimization before treatment.

India's New Transgender Rules Worry Doctors, Disrupt Care

Mehr Khan, an Indian transgender woman, arrived for a routine hormone therapy appointment only to discover the crucial treatment had been suspended after a recent change in the law.

Kailera Shares Tumble on High Nausea Rates Despite Weight-loss Drug's Success

Kailera Therapeutics' shares dropped 10% on Tuesday after its oral weight-loss drug showed high rates ⁠of nausea and vomiting among participants in a late-stage trial in...

Pharmacist-Led Outreach Improves SGLT2 Inhibitor Uptake

Patients with chronic kidney disease and type 2 diabetes receiving pharmacist-led outreach were nearly twice as likely to start an SGLT2 inhibitor as those receiving usual care.

EMA Fast-tracks Review Of Revolutions' Experimental Pancreatic Cancer Pill

The European Medicines Agency said on Tuesday it has begun a rolling review of Revolution ⁠Medicines' experimental treatment for patients with metastatic pancreatic...

Cortisol Normalises by 4 Weeks After Stopping Contraceptives

Serum corticosteroid-binding globulin and total cortisol levels decrease rapidly and normalise within 4 weeks after the cessation of combined oral contraceptives, a Dutch study shows.

Todays Updates

A Sinister Etiology for Shoulder Pain

Patient presented with what was assumed to be rotator cuff injury

Testicular Mass Serendipitously Found 12 Years After Prostate Cancer Dx

Consistently low PSA levels failed to signal metastasis

Study Hints at Survival Benefit With Transplant for Metastatic Lung Cancer

— Substantially longer 1-year survival observed in rare subset of patients with lung-only disease

Todays Updates

A Sinister Etiology for Shoulder Pain

Patient presented with what was assumed to be rotator cuff injury

Testicular Mass Serendipitously Found 12 Years After Prostate Cancer Dx

Consistently low PSA levels failed to signal metastasis

Study Hints at Survival Benefit With Transplant for Metastatic Lung Cancer

— Substantially longer 1-year survival observed in rare subset of patients with lung-only disease

Latest News

BMI appears to have a greater impact on pregnancy continuation than on achieving initial implantation or pregnancy. Study findings suggest promoting proactive BMI optimization before treatment.

Mehr Khan, an Indian transgender woman, arrived for a routine hormone therapy appointment only to discover the crucial treatment had been suspended after a recent change in the law.

Kailera Therapeutics' shares dropped 10% on Tuesday after its oral weight-loss drug showed high rates ⁠of nausea and vomiting among participants in a late-stage trial in...

Patients with chronic kidney disease and type 2 diabetes receiving pharmacist-led outreach were nearly twice as likely to start an SGLT2 inhibitor as those receiving usual care.

The European Medicines Agency said on Tuesday it has begun a rolling review of Revolution ⁠Medicines' experimental treatment for patients with metastatic pancreatic...

Serum corticosteroid-binding globulin and total cortisol levels decrease rapidly and normalise within 4 weeks after the cessation of combined oral contraceptives, a Dutch study shows.

News All Time

First Guideline on Cardiovascular-Kidney-Metabolic Syndrome Released

Guideline targets cardiologists, endocrinologists, nephrologists, and primary care clinicians

The Diabetes Burden Inside and Outside the ADA Conference Hall

Research, funding, policy, and an environmental understanding must all come together

Video: ADA Leader Apologizes to Researchers Ejected From Meeting

CEO says the organization will commission a review of the events

FDA Issues Safety Alert on Weight-Loss Drug's Kidney Risks

All orlistat products will now carry a warning about kidney stones or kidney injury

Endocrine Society Issues First Guideline on Central Precocious Puberty

"Children are entering puberty younger than in past decades," guideline panel co-chair says

Not Enough Men on Testosterone Get Guideline-Based Hypogonadism Work-Up

Data highlight "quite a discrepancy in testosterone prescribing practice," researcher says

Medicare's GLP-1 Program Looms; Chemicals in Breast Milk; Acromegaly Drug Rejected

News and commentary from the endocrinology world

Menopause Experts Release Guidance on Non-Hormone Therapy for Hot Flashes

Comorbidity-specific recommendations will help those with contraindications to hormone therapy

Real-World Study Backs Menopausal Hormone Therapy for Stronger Bones

Clinical guidance still calls for a nuanced approach in postmenopausal women

FTC Sues Leading Transgender Health Group

The suit alleges the group made deceptive claims about gender-affirming care for minors

Lifestyle Treatments as Important as Medications in Managing Obesity in Kids, Teens

Semaglutide combined with counseling "emerged as the most potent intervention"

White House Denies Trump Got Unapproved Obesity Drug

Compassionate use of retatrutide granted for someone with sleep apnea, pulmonary hypertension

Few IVF Add-Ons Have Any Proven Benefits, Study Shows

An evidence-based website could help patients better understand these treatments

Are People With Eating Disorders Misusing GLP-1 Drugs?

This group may be taking the weight-loss drugs in contraindicated ways, researchers suggest

Hospitals in Blue States Continue to Drop Gender-Affirming Care for Youths

One private clinic took on hundreds of patients after health systems stopped

Democrats Press Trump Admin on Special Access to Obesity Drug

If not the president, then who, senator asks

Recommended News For You

Kidney cancer: Understanding what a renal cell carcinoma diagnosis means

Bayer is transforming pharmaceutical research into women's health

Oncologist Sued for Double-Billing; Pharmacy Deserts; 'She Loved Scotch and Pizza'

Guideline on management of early-stage non-small cell lung cancer released

CAR-T Warning for Secondary Malignancies: Warranted or Not?

AI tool identifies women at high risk of interval breast cancer

Both men and women who receive the HPV vaccine have a lower risk of developing multiple cancer types.

Recommended Articles For You

The Power of Salt Tablets: Unlocking Health Benefits Beyond Sodium 

An Analytical and Statistical Journey through Genomic Revolution, Novel Therapeutics, and Future Horizons in Lymphoma 2025 

Exploring the Latest Advances in PTLD Cancer Treatment 

Revolutionizing Cancer Treatment: How Adoptive Cell Therapy is Overcoming Tumor Immune Evasion 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Watch for Psoriasis After Cancer Immunotherapy, Study Says

2.

AI model combines clinical and magnetic resonance data to improve prediction of breast cancer recurrence

3.

Disparities in use of MRI to detect prostate cancer: Race and location may influence testing

4.

Revolutionary Cancer Tx Could Transform Autoimmune Disease

5.

FDA Approves Monthly Dosing of Rybrevant Faspro for NSCLC

1.

Therapeutic Innovations Through Germline Predisposition in Acute Leukemias and Myeloid Neoplasms

2.

Metabolic Symbiosis Within the Tumor Niche: Mechanisms, Clinical Implications, and Therapeutic Opportunities

3.

Bridging the Gap Between Cancer Treatment-Induced Cardiotoxicity and Regenerative Medicine

4.

Glycopyrrolate: The Secret Weapon for Excessive Sweating 

5.

IGSF8: A Rising Star in Cancer Immunotherapy - Harnessing the Innate Immune System

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part III

2.

What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?

3.

The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion

4.

Role of Nimotuzumab in Management of Nasopharyngeal Cancer

5.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot